1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea
structure -
-
CAS No:
26130-02-9
-
Formula:
C15H13N3O2S
-
Chemical Name:
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea
-
Synonyms:
1-(6-methoxy-benzothiazol-2-yl)-3-phenyl-urea; FRENTIZOLE; Frentizol; 1-(6-methoxy-2-benzothiazolyl)-3-phenylurea; 1-(6-methoxybenzo[d]thiazol-2-yl)-3-phenylurea;
- Categories:
-
CAS No:
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Basic Attributes
299.34800
299.07284784 g/mol
7EY946394I
DTXSID5046279
2934999090
Safety Information
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P273, P280, P301+P312, P305+P351+P338, P330, P337+P313, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Computed Properties
Molecular Weight:299.3
XLogP3:3.2
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:3
Exact Mass:299.07284784
Monoisotopic Mass:299.07284784
Topological Polar Surface Area:91.5
Heavy Atom Count:21
Complexity:363
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of 1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea
-
![United States]()
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates
Latest News on 1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
L-Tyrosyl-L-phenylalanine Formula
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
Sildenafil Structure
139755-83-2
-
What is Dacomitinib
1110813-31-4
-
What is Lenvatinib
417716-92-8
Request for Quotation